- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acetylcholinesterase inhibitors, Anticholinergics, Antihistamines, Botulinum Toxin (A & B), Cannabinoids, Conivaptan, Disopyramide, Domperidone, Haloperidol, Ketoconazole, Levodopa, MAO inhibitors, Memantine, Metoclopramide, Nefopam, Parasympathomimetics, PEG-Interferon, Phenothiazines, Potassium chloride, Pramlintide, Secretin, Sublingual nitrates, Tricyclic antidepressants
Stiolto Respimat is tiotropium and olodaterol.
Please login to view the rest of this drug profile.
DRUG REVIEW ARTICLE
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of tiotropium in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 03/15/2024